Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Longenecker, BM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 43 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Handa, K; Jacobs, F; Longenecker, BM; Hakomori, S
      Association of MUC-1 and PSGL-1 with low-density microdomain in T-lymphocytes: A preliminary note (vol 285, pg 788, 2001)

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    2. Handa, K; Jacobs, F; Longenecker, BM; Hakomori, S
      Association of MUC-1 and PSGL-1 with low-density microdomain in T-lymphocytes: A preliminary note

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    3. Moase, EH; Qu, W; Ishida, T; Gabos, Z; Longenecker, BM; Zimmermann, GL; Ding, L; Krantz, M; Allen, TM
      Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer

      BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
    4. Zimmermann, GL; Krantz, MJ; Kane, KP; Longenecker, BM
      A low-level expression of human MUC1 mucin enhances lethality of murine tumor cells

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    5. Schuman, J; Qiu, DX; Koganty, RR; Longenecker, BM; Campbell, AP
      Glycosylations versus conformational preferences of cancer associated mucin core

      GLYCOCONJUGATE JOURNAL
    6. Holmberg, LA; Oparin, DV; Gooley, T; Lilleby, K; Bensinger, W; Reddish, MA; MacLean, GD; Longenecker, BM; Sandmaier, BM
      Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE (R) STn-KLH cancer vaccine

      BONE MARROW TRANSPLANTATION
    7. Sandmaier, BM; Oparin, DV; Holmberg, LA; Reddish, MA; MacLean, GD; Longenecker, BM
      Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with theratope STn-KLH cancer vaccine

      JOURNAL OF IMMUNOTHERAPY
    8. Ragupathi, G; Howard, L; Cappello, S; Koganty, RR; Qiu, DX; Longenecker, BM; Reddish, MA; Lloyd, KO; Livingston, PO
      Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimalantibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    9. Hwang, IR; Nahm, DH; Cho, SN; Longenecker, BM; Koganty, RR; Park, IS
      Anti-T antibodies and peanut-agglutinin-binding glycoproteins in sera of patients with gastric cancer

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    10. AGRAWAL B; GENDLER SJ; LONGENECKER BM
      THE BIOLOGICAL ROLE OF MUCINS IN CELLULAR INTERACTIONS AND IMMUNE REGULATION - PROSPECTS FOR CANCER-IMMUNOTHERAPY

      Molecular medicine today
    11. AGRAWAL B; KRANTZ MJ; REDDISH MA; LONGENECKER BM
      CANCER-ASSOCIATED MUC1 MUCIN INHIBITS HUMAN T-CELL PROLIFERATION, WHICH IS REVERSIBLE BY IL-2

      Nature medicine
    12. GUAN HH; BUDZYNSKI W; KOGANTY RR; KRANTZ MJ; REDDISH MA; ROGERS JA; LONGENECKER BM; SAMUEL J
      LIPOSOMAL FORMULATIONS OF SYNTHETIC MUC1 PEPTIDES - EFFECTS OF ENCAPSULATION VERSUS SURFACE DISPLAY OF PEPTIDES ON IMMUNE-RESPONSES

      Bioconjugate chemistry
    13. REDDISH MA; SURESH MR; KOGANTY RR; FORTIER S; BARONIC L; BERG A; MICHAEL B; LONGENECKER BM
      ANALYSIS OF THE ROLE OF TYPE-1 CORE O-GLYCANS IN THE BINDING OF ANTI-MUC1 ANTIBODIES BY CYTOFLUOROMETRY AND SYNTHETIC PEPTIDE GLYCOPEPTIDE BINDING-INHIBITION STUDIES/

      Tumor biology
    14. Agrawal, B; Krantz, MJ; Reddish, MA; Longenecker, BM
      Rapid induction of primary human CD4(+) and CD8(+) T cell responses against cancer-associated MUC1 peptide epitopes

      INTERNATIONAL IMMUNOLOGY
    15. OGATA S; KOGANTY R; REDDISH M; LONGENECKER BM; CHEN AL; PEREZ C; ITZKOWITZ SH
      DIFFERENT MODES OF SIALYL-TN EXPRESSION DURING MALIGNANT TRANSFORMATION OF HUMAN COLONIC MUCOSA

      Glycoconjugate journal
    16. REDDISH MA; MACLEAN GD; KOGANTY RR; KANMITCHELL J; JONES V; MITCHELL MS; LONGENECKER BM
      ANTI-MUC1 CLASS-I RESTRICTED CTLS IN METASTATIC BREAST-CANCER PATIENTS IMMUNIZED WITH A SYNTHETIC MUC1 PEPTIDE

      International journal of cancer
    17. SAMUEL J; BUDZYNSKI WA; REDDISH MA; DING L; ZIMMERMANN GL; KRANTZ MJ; KOGANTY RR; LONGENECKER BM
      IMMUNOGENICITY AND ANTITUMOR-ACTIVITY OF A LIPOSOMAL MUC1 PEPTIDE-BASED VACCINE

      International journal of cancer
    18. AGRAWAL B; REDDISH MA; CHRISTIAN B; VANHEELE A; TANG L; KOGANTY RR; LONGENECKER BM
      THE ANTI-MUC1 MONOCLONAL-ANTIBODY BCP8 CAN BE USED TO ISOLATE AND IDENTIFY PUTATIVE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I ASSOCIATED AMINO-ACID-SEQUENCES

      Cancer research
    19. AGRAWAL B; KRANTZ MJ; PARKER J; LONGENECKER BM
      EXPRESSION OF MUC1 MUCIN ON ACTIVATED HUMAN T-CELLS - IMPLICATIONS FOR A ROLE OF MUC1 IN NORMAL IMMUNE REGULATION

      Cancer research
    20. Kam, JL; Regimbald, LH; Hilgers, JHM; Hoffman, P; Krantz, MJ; Longenecker, BM; Hugh, JC
      MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 andMUC1 binding requires six tandem repeats

      CANCER RESEARCH
    21. MACLEAN GD; REDDISH MA; LONGENECKER BM
      PROGNOSTIC-SIGNIFICANCE OF PREIMMUNOTHERAPY SERUM CA27.29 (MUC-1) MUCIN LEVEL AFTER ACTIVE SPECIFIC IMMUNOTHERAPY OF METASTATIC ADENOCARCINOMA PATIENTS

      Journal of immunotherapy with emphasis on tumor immunology
    22. REDDISH MA; JACKSON L; KOGANTY RR; QIU DX; HONG W; LONGENECKER BM
      SPECIFICITIES OF ANTI-SIALYL-TN AND ANTI-TN MONOCLONAL-ANTIBODIES GENERATED USING NOVEL CLUSTERED SYNTHETIC GLYCOPEPTIDE EPITOPES

      Glycoconjugate journal
    23. KOGANTY RR; REDDISH MA; LONGENECKER BM
      GLYCOPEPTIDE-BASED AND CARBOHYDRATE-BASED SYNTHETIC VACCINES FOR THE IMMUNOTHERAPY OF CANCER

      Drug discovery today
    24. MACLEAN GD; MILES DW; RUBENS RD; REDDISH MA; LONGENECKER BM
      ENHANCING THE EFFECT OF THERATOPE STN-KLH CANCER VACCINE IN PATIENTS WITH METASTATIC BREAST-CANCER BY PRETREATMENT WITH LOW-DOSE INTRAVENOUS CYCLOPHOSPHAMIDE

      Journal of immunotherapy with emphasis on tumor immunology
    25. MACLEAN GD; REDDISH MA; KOGANTY RR; LONGENECKER BM
      ANTIBODIES AGAINST MUCIN-ASSOCIATED SIALYL-TN EPITOPES CORRELATE WITHSURVIVAL OF METASTATIC ADENOCARCINOMA PATIENTS UNDERGOING ACTIVE SPECIFIC IMMUNOTHERAPY WITH SYNTHETIC STN VACCINE

      Journal of immunotherapy with emphasis on tumor immunology
    26. REDDISH MA; MACLEAN GD; POPPEMA S; BERG A; LONGENECKER BM
      PRE-IMMUNOTHERAPY SERUM CA27.29 (MUC-1) MUCIN LEVEL AND CD69(-TN-KLH CANCER VACCINE IN ACTIVE SPECIFIC IMMUNOTHERAPY() LYMPHOCYTES CORRELATE WITH EFFECTS OF THERATOPE(R) SIALYL)

      Cancer immunology and immunotherapy
    27. OBOYLE KP; MARKOWITZ AL; KHORSHIDI M; LALEZARI P; LONGENECKER BM; LLOYD KO; WELT S; WRIGHT KE
      SPECIFICITY ANALYSIS OF MURINE MONOCLONAL-ANTIBODIES REACTIVE WITH TN, SIALYLATED TN, T, AND MONOSIALYLATED (2-]6) T ANTIGENS

      Hybridoma
    28. AGRAWAL B; REDDISH M; LONGENECKER BM
      CD30 EXPRESSION ON HUMAN CD8-CELLS ISOLATED FROM PERIPHERAL-BLOOD LYMPHOCYTES OF NORMAL DONORS( T)

      The Journal of immunology
    29. AGRAWAL B; REDDISH MA; LONGENECKER BM
      IN-VITRO INDUCTION OF MUC-1 PEPTIDE-SPECIFIC TYPE-1 T-LYMPHOCYTE AND CYTOTOXIC T-LYMPHOCYTE RESPONSES FROM HEALTHY MULTIPAROUS DONORS

      The Journal of immunology
    30. REGIMBALD LH; PILARSKI LM; LONGENECKER BM; REDDISH MA; ZIMMERMANN G; HUGH JC
      THE BREAST MUCIN MUC1 AS A NOVEL ADHESION LIGAND FOR ENDOTHELIAL INTERCELLULAR-ADHESION MOLECULE-1 IN BREAST-CANCER

      Cancer research
    31. MILES DW; TOWLSON KE; GRAHAM R; REDDISH M; LONGENECKER BM; TAYLORPAPADIMITRIOU J; RUBENS RD
      A RANDOMIZED PHASE-II STUDY OF SIALYL-TN AND DETOX-B ADJUVANT WITH ORWITHOUT CYCLOPHOSPHAMIDE PRETREATMENT FOR THE ACTIVE SPECIFIC IMMUNOTHERAPY OF BREAST-CANCER

      British Journal of Cancer
    32. YACYSHYN BR; LONGENECKER BM; BIERMANN WA; MCCLURE D; POPPEMA S; BOWENYACYSHYN MB
      ACTIVE SPECIFIC IMMUNOTHERAPY IN THE MANAGEMENT OF ADENOCARCINOMA OF THE PANCREAS

      Canadian journal of gastroenterology
    33. REDDISH MA; BUSZYNSKI V; DING L; LONGENECKER BM
      ACTIVE SPECIFIC IMMUNOTHERAPY OF ADENOCARCINOMAS WITH SYNTHETIC TUMOR-ASSOCIATED ANTIGENS CONJUGATED TO KEYHOLE LIMPET HEMOCYANIN

      Onkologie
    34. LIU XH; SEJBAL J; KOTOVYCH G; KOGANTY RR; REDDISH MA; JACKSON L; GANDHI SS; MENDONCA AJ; LONGENECKER BM
      STRUCTURALLY DEFINED SYNTHETIC CANCER VACCINES - ANALYSIS OF STRUCTURE, GLYCOSYLATION AND RECOGNITION OF CANCER-ASSOCIATED MUCIN, MUC-1 DERIVED PEPTIDES

      Glycoconjugate journal
    35. YACYSHYN MBB; POPPEMA S; BERG A; MACLEAN GD; REDDISH MA; MEIKLE A; LONGENECKER BM
      CD69(-DR(+) ACTIVATION ANTIGENS ON PERIPHERAL-BLOOD LYMPHOCYTE POPULATIONS IN METASTATIC BREAST AND OVARIAN-CANCER PATIENTS - CORRELATIONS WITH SURVIVAL FOLLOWING ACTIVE SPECIFIC IMMUNOTHERAPY() AND HLA)

      International journal of cancer
    36. ZHANG SL; WALBERG LA; OGATA S; ITZKOWITZ SH; KOGANTY RR; REDDISH M; GANDHI SS; LONGENECKER BM; LLOYD KO; LIVINGSTON PO
      IMMUNE SERA AND MONOCLONAL-ANTIBODIES DEFINE 2 CONFIGURATIONS FOR THESIALYL-TN TUMOR-ANTIGEN

      Cancer research
    37. HELLING F; ZHANG S; SHANG A; ADLURI S; CALVES M; KOGANTY R; LONGENECKER BM; YAO TJ; OETTGEN HF; LIVINGSTON PO
      G(M2)-KLH CONJUGATE VACCINE - INCREASED IMMUNOGENICITY IN MELANOMA PATIENTS AFTER ADMINISTRATION WITH IMMUNOLOGICAL ADJUVANT QS-21

      Cancer research
    38. AGRAWAL B; REDDISH MA; KRANTZ MJ; LONGENECKER BM
      DOES PREGNANCY IMMUNIZE AGAINST BREAST-CANCER

      Cancer research
    39. MACLEAN GD; LONGENECKER BM
      PROSPECTS FOR AN IMMUNOLOGICAL APPROACH TO THERAPY OF OVARIAN-CANCER

      CLINICAL IMMUNOTHERAPEUTICS
    40. MACLEAN GD; REDDISH MA; BOWENYACYSHYN MB; POPPEMA S; LONGENECKER BM
      ACTIVE SPECIFIC IMMUNOTHERAPY AGAINST ADENOCARCINOMAS

      Cancer investigation
    41. HO I; OGATA S; CHEN A; WEISS A; REDDISH M; LONGENECKER BM; ITZKOWITZ SH
      ADOPTIVE TRANSFER OF LYMPHOCYTES SENSITIZED TO SIALOSYL-TN(STN) ANTIGEN PROLONGS SURVIVAL IN RAT COLON-CANCER

      Gastroenterology
    42. YACYSHYN BR; LONGENECKER BM; POPPEMA S; BOWENYACYSHYN MB
      ACTIVE SPECIFIC IMMUNOTHERAPY FOR PANCREATIC ADENOCARCINOMA

      Gastroenterology
    43. MORO R; TAMAOKI T; WEGMANN TG; LONGENECKER BM; LADEROUTE MP
      MONOCLONAL-ANTIBODIES DIRECTED AGAINST A WIDESPREAD ONCOFETAL ANTIGEN- THE ALPHA-FETOPROTEIN RECEPTOR

      Tumor biology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/01/21 alle ore 22:36:38